Viral Shah
Dr. Viral Shah is an endocrinologist and the director of diabetes clinical research at the Indiana University School of Medicine. He is actively involved in exploring new treatment options for diabetes, including the use of GLP-1 medications in patients with type 1 diabetes, contributing to ongoing studies that aim to better understand the potential benefits and risks of these medications.
Not in the pool (under ¢1).
Recent news mentions
Viral Shah assessed the damages caused by looters at his supermarket.
As families mourn their loved ones, traders count losses after violence
Kenya· 2025-07-09
Viral Shah is the study supervisor at the Indiana University School of Medicine.
دراسة تُظهر تحسناً في إدارة السكري من النوع الأول والسمنة
United Arab Emirates· 2025-06-29Viral Shah is the study supervisor at Indiana University School of Medicine who reported the findings of the trial.
دواء جديد يعطي أملا لمرضى السكري من النوع الأول
Saudi Arabia· 2025-06-29Dr. Viral Shah is an endocrinologist and director of diabetes clinical research at the Indiana University School of Medicine.
More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness
United States· 2025-04-09